-
161
Corrigendum to “An Unusual Cause of Bleeding in a Patient with Chronic Myeloid Leukemia Chronic Phase”
Published 2020-01-01Get full text
Article -
162
Disseminated Exfoliative Dermatitis Associated with All-Transretinoic Acid in the Treatment of Acute Promyelocytic Leukemia
Published 2012-01-01“…Acute promyelocytic leukemia (APL) is a biologically and clinically separate type of acute myeloid leukemia characterized by a translocation involving the retinoic acid receptor-alpha (RARa) locus on chromosome 17, the great majority of which is t(15; 17)(q24.1; q21.1) (Collins (1998), Melnick and Licht (1999), and Grimwade (1999)). …”
Get full text
Article -
163
PI3K/AKT/PTEN Signaling as a Molecular Target in Leukemia Angiogenesis
Published 2012-01-01“…PI3K/AKT/PTEN pathway is important in the regulation of angiogenesis mediated by vascular endothelial growth factor in many tumors including leukemia. The signaling pathway is activated in leukemia patients as well as leukemia cell lines together with a decrease in the expression of PTEN gene. …”
Get full text
Article -
164
Recurrence of Chronic Myeloid Leukemia during Pregnancy Subsequently Achieving Complete Medical Remission
Published 2017-01-01“…The treatment of chronic myeloid leukemia (CML) with tyrosine kinase inhibitors (TKIs) in reproductive-aged women poses major dilemmas concerning its associated teratogenicity as observed in many animal studies. …”
Get full text
Article -
165
HLA-G Expression on Blasts and Tolerogenic Cells in Patients Affected by Acute Myeloid Leukemia
Published 2014-01-01“…However, the role of HLA-G expression and functions in Acute Myeloid Leukemia (AML) is still controversial. Our group identified a subset of tolerogenic dendritic cells, DC-10 that express HLA-G and secrete IL-10. …”
Get full text
Article -
166
Treatment Sequencing in a Chronic Lymphocytic Leukemia Patient with Central Nervous System Involvement
Published 2018-01-01“…Early-stage chronic lymphocytic leukemia (CLL) with neurologic involvement is a rare condition and should require a careful follow-up. …”
Get full text
Article -
167
Extramedullary Hematopoiesis in a Sentinel Lymph Node as an Early Sign of Chronic Myelomonocytic Leukemia
Published 2015-01-01“…Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic malignancy with features of both a myeloproliferative neoplasm and a myelodysplastic syndrome. …”
Get full text
Article -
168
Chronic Eosinophilic Leukemia—Not Otherwise Specified (NOS) in the Background of a Large Cell Lymphoma
Published 2013-01-01“…The presence of a primary clonal eosinophilic disorder such as chronic eosinophilic leukemia—not otherwise specified (NOS) in the presence of a synchronous large cell lymphoma—is rare making the diagnosis challenging. …”
Get full text
Article -
169
Anuric Acute Kidney Injury in Chronic Myeloid Leukemia: A Rare Complication Case
Published 2024-10-01Subjects: Get full text
Article -
170
Hematopoietic cell transplantation soon after first relapse in acute myeloid leukemia – the PROS
Published 2025-01-01Get full text
Article -
171
Pediatric and adolescent chronic myeloid leukemia: A follow-up study in Western India
Published 2023-07-01Subjects: “…child chronic myeloid leukemia…”
Get full text
Article -
172
Hotspots evolution and frontiers of immunotherapy for the treatment of acute myeloid leukemia: A bibliometric analysis
Published 2025-12-01Subjects: “…Acute myeloid leukemia…”
Get full text
Article -
173
Malignant Phyllodes Tumor and Acute Megakaryoblastic Leukemia Sharing a Common Clonal Origin
Published 2013-01-01“…There is a well-known association in male patients between mediastinal germ cell tumors (GCT) and hematologic malignancies, with a propensity towards acute megakaryoblastic leukemia. These rare malignancies have been shown to share a common clonal origin, often deduced from the finding of isochromosome 12p, i(12p), in cells from both the solid tumor and the leukemia, and thus are now known to represent different manifestations of the same clonal process. …”
Get full text
Article -
174
Computational assessment of measurable residual disease in acute myeloid leukemia using mixture models
Published 2024-12-01“…Abstract Background The proportion of residual leukemic blasts after chemotherapy assessed by multiparameter flow cytometry, is an important prognostic factor for the risk of relapse and overall survival in acute myeloid leukemia (AML). This measurable residual disease (MRD) is used in clinical trials to stratify patients for more or less intensive consolidation therapy. …”
Get full text
Article -
175
Yinzhihuang injection induces apoptosis and suppresses tumor growth in acute myeloid leukemia cells.
Published 2023-01-01“…<h4>Background</h4>The unmet needs in treating acute myeloid leukemia(AML) promote us to look for more effective and less toxic therapies. …”
Get full text
Article -
176
Diagnostic utility of LMO2 immunohistochemistry in distinguishing T-lymphoblastic leukemia/lymphoma from thymoma
Published 2023-01-01“…Distinguishing T-lymphoblastic leukemia/lymphoma (T-ALL/T-LBL) from thymomas (especially B1 or B2 type) can be challenging particularly in limited trucut biopsy material where appreciating architecture is difficult or the background epithelial component does not provide tangible evidence for definite diagnosis. …”
Get full text
Article -
177
-
178
PRMT1 Promotes the Self‐renewal of Leukemia Stem Cells by Regulating Protein Synthesis
Published 2025-02-01Subjects: Get full text
Article -
179
We still need to hit hard in acute myeloid leukemia, but only in the right patients
Published 2025-01-01Get full text
Article -
180
Vertigo as the First Sign of Chronic Myeloid Leukemia: A Case Report and Literature Review
Published 2013-01-01“…Acute vestibular deficit as the first sign of leukemia is extremely rare. The literature shows some cases of sudden hearing loss accompanied by instability and associated with hyperviscosity syndrome. …”
Get full text
Article